Myocardialinfarction
To the Editor:
In a recent Case Report (1) the abnormal electrocardiographic findings were not confirmed by the enzyme changes as is usually the case in documented myocardial infarction.
We would like to point out that some work has been done indicating that serum zinc concentrations decline rapidly after a myocardial infarct (2, 3) . After four days the concentration gradually increased to within normal limits (2) . This was generally the case in 11 patients who fulfilled all other criteria for myocardial infarction. In contrast, there was no comparable change in the serum zinc concentrations of seven patients who had chest pains caused by myocardial ischemia without the electrocardiographic or enzyme changes characteristic of infarction.
Therefore measurement of plasma or serum zinc may be helpful in diagnosing myocardial infarction. Although determination of zinc in body fluids is somewhat complex and requires special instrumentation, it is becoming increasingly available. Zinc in plasma can be measured with precision and accuracy by atomic absorption spectroscopy (4) . Special precautions must be taken to prevent contamination in view of the fact that zinc is ubiquitous in the environment. The usual evacuated tubes used for drawing blood contaminate the sample and invalidate the results. However, if the sample has been properly obtained without contamination (4) bration. Moreover, in a serial analysis of six samples from a tonometered blood containing 1% halothane, the po2 value increased with each succeeding aliquot, indicating that the contamination effect was cumulative. Of the various types of blood gas instruments in our laboratory, the IL 813 blood gas analyzer (Instrumentation Laboratory Inc., Lexington, MA 02173) has been used most frequently to determine po2 in blood samples from patients anesthetized with halothane, as well as from other patients in the acute-care units. Although no unusual drift of the P02 electrode calibration had been observed after exposure of the po2 electrode of our IL 813 instrument to blood containing halothane, we decided that the possibility of halothane contamination needed investigation.
With infants and pediatric patients, the size of blood sample available often is so small as to preclude duplicate samples; therefore, our interest was focused on the performance of the po2 electrode exposed only once to a blood sample of a patient receiving halothane. 
The protocol of the experiment was designed as follows. In the morning, the instrument was prepared for operation by calibration and verification with whole blood gas control samples 
Comparison of Radioimmunoassay Results in Serum and Plasma
In recent reports Kubasik and Sine have compared serum and plasma results for a total of 25 analytes in 31 different radioassay procedures (1, 2).
They found statistically significant differences, some of substantial magnitude, between sample types for many of these procedures. No apparent predictor exists regarding which assays will be affectedby sample type: each kit or reagent system must be evaluated separately. Here, I report results for serum and for plasma treated with ethylenediaminetetraacetate (EDTA) or heparin, as determined in 12 radioimmunoassay (RIA) procedures in our laboratory.
I evaluated the following kits and component systems using the manufacturer's suggested protocols: Progesterone: "Progesterone radio-
immunoassay kit"; CIS Radiopharmaceuticals.
Prolactin:
"Prolactin radioimmunoassay kit"; CIS Radiopharmaceuticals. Testosterone (antisera and tritiated steriod): Radioassay Systems Laboratories, Inc., Carson, CA 90746; standard from Sigma Chemical Co.
Thyrotropin: "Quantitope 125 IThyroid-stimulating hormone radioimmunoassay kit"; Kallestad Labs.
Supernates of the tritiated steroid assays (estradiol, estrone, progesterone, and testosterone) were decanted into 10 mL of Biocount (Research Products International, Elk Grove, IL 60007) scintillation cocktail and counted with a Tri-Carb Liquid Scintillation System (Model 2425; Packard Instrument Co., Downers Grove, IL 60515). The remaining assays, which involved 1251, were counted with a Packard AutoGamma Scintillation Counter (Model 5360).
I used a Hewlett-Packard 9810 desktop calculator and a weighted leastsquares regression of a logit-log plot to evaluate the radioimmunoassay data Plasma samples were immediately separated from the cells in a refrigerated centrifuge (3000 X g, 10 mm, 4 #{176}C). Serum samples were allowed to clot at 4 #{176}C, then separated in the same centrifuge. Plasmas and sera were aliquoted and frozen immediately after centrifugation. One heparin-containing tube was broken, so that n = 12 for heparintreated plasma and 13 for EDTAtreated plasma and for serum.
All subjects were in good health. Blood samples were obtained between 0800 and 1000 h, after an overnight fast.
Hormonal
and cycle-day data indicate that five of the women were in the follicular phase of their menstrual cycles, two in the luteal stage, and one postmenopausal. None were taking oral contraceptivesor other hormonal medication.
Because In sixof the 11 procedures shown in Table 1 , the differences in results were statistically significant between the two sample types: mean assayed values were lower for EDTA-treated plasma than for serum. The decrease was small in most cases, but could be clinically relevant in a borderline abnormal sample. The apparently normal volunteers in this study provided samples for analysis over a wide range of values for the reproductive hormones.
For such analytes as somatotropin and thyrotropin, however, all values fell well within the normal range. I do not know whether a sample with above-normal concentrations of these hormones would show proportionally greater or lesser discrepancy between serum and EDTA-treated plasma.
The comparison of results from serum with those from heparin-treated plasma in all assays except corticotropin showed no statistically significant differences (see Table 2 ).
In the assay for corticotropin, serum values (17.0 ng/L, SD 28.5 ng/L) are significantlyless (p <0.01, n = 13) than those in EDTA-treated plasma (29.0 ng/L, SD 28.3 ng/L), the specimen of choice. This is because of the lability of corticotropin in the presence of eryth-
